Literature DB >> 25840590

Telomere dysfunction causes alveolar stem cell failure.

Jonathan K Alder1, Christina E Barkauskas2, Nathachit Limjunyawong3, Susan E Stanley1, Frant Kembou1, Rubin M Tuder4, Brigid L M Hogan5, Wayne Mitzner3, Mary Armanios6.   

Abstract

Telomere syndromes have their most common manifestation in lung disease that is recognized as idiopathic pulmonary fibrosis and emphysema. In both conditions, there is loss of alveolar integrity, but the underlying mechanisms are not known. We tested the capacity of alveolar epithelial and stromal cells from mice with short telomeres to support alveolar organoid colony formation and found that type 2 alveolar epithelial cells (AEC2s), the stem cell-containing population, were limiting. When telomere dysfunction was induced in adult AEC2s by conditional deletion of the shelterin component telomeric repeat-binding factor 2, cells survived but remained dormant and showed all the hallmarks of cellular senescence. Telomere dysfunction in AEC2s triggered an immune response, and this was associated with AEC2-derived up-regulation of cytokine signaling pathways that are known to provoke inflammation in the lung. Mice uniformly died after challenge with bleomycin, underscoring an essential role for telomere function in AEC2s for alveolar repair. Our data show that alveoloar progenitor senescence is sufficient to recapitulate the regenerative defects, inflammatory responses, and susceptibility to injury that are characteristic of telomere-mediated lung disease. They suggest alveolar stem cell failure is a driver of telomere-mediated lung disease and that efforts to reverse it may be clinically beneficial.

Entities:  

Keywords:  emphysema; idiopathic pulmonary fibrosis; senescence; telomerase

Mesh:

Substances:

Year:  2015        PMID: 25840590      PMCID: PMC4413294          DOI: 10.1073/pnas.1504780112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis.

Authors:  L Chin; S E Artandi; Q Shen; A Tam; S L Lee; G J Gottlieb; C W Greider; R A DePinho
Journal:  Cell       Date:  1999-05-14       Impact factor: 41.582

2.  Hepatocytes with extensive telomere deprotection and fusion remain viable and regenerate liver mass through endoreduplication.

Authors:  Eros Lazzerini Denchi; Giulia Celli; Titia de Lange
Journal:  Genes Dev       Date:  2006-10-01       Impact factor: 11.361

Review 3.  Immunologic aspects of chronic obstructive pulmonary disease.

Authors:  Manuel G Cosio; Marina Saetta; Alvar Agusti
Journal:  N Engl J Med       Date:  2009-06-04       Impact factor: 91.245

4.  Short telomeres, even in the presence of telomerase, limit tissue renewal capacity.

Authors:  Ling-Yang Hao; Mary Armanios; Margaret A Strong; Baktiar Karim; David M Feldser; David Huso; Carol W Greider
Journal:  Cell       Date:  2005-12-16       Impact factor: 41.582

5.  Combined pulmonary fibrosis and emphysema syndrome associated with familial SFTPC mutation.

Authors:  Vincent Cottin; Philippe Reix; Chahéra Khouatra; Françoise Thivolet-Béjui; Delphine Feldmann; Jean-François Cordier
Journal:  Thorax       Date:  2011-01-19       Impact factor: 9.139

6.  Alveolar cell senescence in patients with pulmonary emphysema.

Authors:  Takao Tsuji; Kazutetsu Aoshiba; Atsushi Nagai
Journal:  Am J Respir Crit Care Med       Date:  2006-08-03       Impact factor: 21.405

7.  Telomerase mutations in families with idiopathic pulmonary fibrosis.

Authors:  Mary Y Armanios; Julian J-L Chen; Joy D Cogan; Jonathan K Alder; Roxann G Ingersoll; Cheryl Markin; William E Lawson; Mingyi Xie; Irma Vulto; John A Phillips; Peter M Lansdorp; Carol W Greider; James E Loyd
Journal:  N Engl J Med       Date:  2007-03-29       Impact factor: 91.245

8.  Dyskeratosis congenita: advances in the understanding of the telomerase defect and the role of stem cell transplantation.

Authors:  Josu de la Fuente; Inderjeet Dokal
Journal:  Pediatr Transplant       Date:  2007-09

9.  Short telomeres are a risk factor for idiopathic pulmonary fibrosis.

Authors:  Jonathan K Alder; Julian J-L Chen; Lisa Lancaster; Sonye Danoff; Shu-chih Su; Joy D Cogan; Irma Vulto; Mingyi Xie; Xiaodong Qi; Rubin M Tuder; John A Phillips; Peter M Lansdorp; James E Loyd; Mary Y Armanios
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-27       Impact factor: 11.205

10.  Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor.

Authors:  Jean-Philippe Coppé; Christopher K Patil; Francis Rodier; Yu Sun; Denise P Muñoz; Joshua Goldstein; Peter S Nelson; Pierre-Yves Desprez; Judith Campisi
Journal:  PLoS Biol       Date:  2008-12-02       Impact factor: 8.029

View more
  135 in total

Review 1.  The molecular genetics of the telomere biology disorders.

Authors:  Alison A Bertuch
Journal:  RNA Biol       Date:  2015-09-23       Impact factor: 4.652

2.  Airway Epithelial Telomere Dysfunction Drives Remodeling Similar to Chronic Lung Allograft Dysfunction.

Authors:  Ram P Naikawadi; Gary Green; Kirk D Jones; Natalia Achtar-Zadeh; Julia E Mieleszko; Isabel Arnould; Jasleen Kukreja; John R Greenland; Paul J Wolters
Journal:  Am J Respir Cell Mol Biol       Date:  2020-10       Impact factor: 6.914

Review 3.  Lung regeneration: a tale of mice and men.

Authors:  Maria C Basil; Edward E Morrisey
Journal:  Semin Cell Dev Biol       Date:  2019-11-21       Impact factor: 7.727

4.  Telomere length in patients with pulmonary fibrosis associated with chronic lung allograft dysfunction and post-lung transplantation survival.

Authors:  Chad A Newton; Julia Kozlitina; Jefferson R Lines; Vaidehi Kaza; Fernando Torres; Christine Kim Garcia
Journal:  J Heart Lung Transplant       Date:  2017-02-04       Impact factor: 10.247

5.  IPF lung fibroblasts have a senescent phenotype.

Authors:  Diana Álvarez; Nayra Cárdenes; Jacobo Sellarés; Marta Bueno; Catherine Corey; Vidya Sagar Hanumanthu; Yating Peng; Hannah D'Cunha; John Sembrat; Mehdi Nouraie; Swaroop Shanker; Chandler Caufield; Sruti Shiva; Mary Armanios; Ana L Mora; Mauricio Rojas
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-08-31       Impact factor: 5.464

Review 6.  A regulatory loop connecting WNT signaling and telomere capping: possible therapeutic implications for dyskeratosis congenita.

Authors:  Rafael Jesus Fernandez; F Brad Johnson
Journal:  Ann N Y Acad Sci       Date:  2018-04       Impact factor: 5.691

7.  Disruption of direct 3D telomere-TRF2 interaction through two molecularly disparate mechanisms is a hallmark of primary Hodgkin and Reed-Sternberg cells.

Authors:  Hans Knecht; Nathalie A Johnson; Tina Haliotis; Daniel Lichtensztejn; Sabine Mai
Journal:  Lab Invest       Date:  2017-04-24       Impact factor: 5.662

8.  Telomere dysfunction in alveolar epithelial cells causes lung remodeling and fibrosis.

Authors:  Ram P Naikawadi; Supparerk Disayabutr; Benat Mallavia; Matthew L Donne; Gary Green; Janet L La; Jason R Rock; Mark R Looney; Paul J Wolters
Journal:  JCI Insight       Date:  2016-09-08

9.  Hyaluronan and TLR4 promote surfactant-protein-C-positive alveolar progenitor cell renewal and prevent severe pulmonary fibrosis in mice.

Authors:  Jiurong Liang; Yanli Zhang; Ting Xie; Ningshan Liu; Huaiyong Chen; Yan Geng; Adrianne Kurkciyan; Jessica Monterrosa Mena; Barry R Stripp; Dianhua Jiang; Paul W Noble
Journal:  Nat Med       Date:  2016-10-03       Impact factor: 53.440

Review 10.  Cell Death in the Lung: The Apoptosis-Necroptosis Axis.

Authors:  Maor Sauler; Isabel S Bazan; Patty J Lee
Journal:  Annu Rev Physiol       Date:  2018-11-28       Impact factor: 19.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.